Tom Plitz

Tom Plitz is a seasoned biotechnology entrepreneur and Chief Executive Officer currently leading Precirix, a clinical-stage biopharmaceutical company focused on developing innovative radiopharmaceuticals. They previously served as the Chief Executive Officer at CHORD Therapeutics and the Chief Scientific Officer at Wilson Therapeutics, alongside roles at notable companies such as Merck Group and Shire Pharmaceuticals. Tom has held various positions in product development and clinical research over their career, including Vice Chairman of the Board at RELIEF THERAPEUTICS. They earned both a Master's degree and a PhD in biology from Technical University Munich, completing their studies in the mid-1990s.